Emily M. Leproust
2019
In 2019, Emily M. Leproust earned a total compensation of $8.1M as President, Chief Executive Officer and Chair at Twist Bioscience Corp, a 1,449% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $458,752 |
|---|---|
| Option Awards | $4,144,965 |
| Salary | $477,042 |
| Stock Awards | $3,045,398 |
| Total | $8,126,157 |
Leproust received $4.1M in option awards, accounting for 51% of the total pay in 2019.
Leproust also received $458.8K in non-equity incentive plan, $477K in salary and $3M in stock awards.
Rankings
In 2019, Emily M. Leproust's compensation ranked 1,063rd out of 13,971 executives tracked by ExecPay. In other words, Leproust earned more than 92.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,063 out of 13,971 | 92nd |
Division Manufacturing | 364 out of 5,692 | 94th |
Major group Chemicals And Allied Products | 109 out of 2,189 | 95th |
Industry group Drugs | 85 out of 1,875 | 96th |
Industry Biological Products, Except Diagnostic Substances | 16 out of 389 | 96th |
Source: SEC filing on January 7, 2021.
Leproust's colleagues
We found two more compensation records of executives who worked with Emily M. Leproust at Twist Bioscience Corp in 2019.
News
Twist Bioscience Corp CEO Emily Leproust's 2022 pay jumps 362% to $5.9M
January 6, 2023
Twist Bioscience Corp CEO Emily Leproust's 2021 pay falls 83% to $1.3M
January 4, 2022
Twist Bioscience Corp CEO Emily Leproust's 2020 pay slips 8% to $7.4M
January 7, 2021
Twist Bioscience Corp CFO James Thorburn receives $1.5M in 2018
June 14, 2019